Price Transparency: Progress, But Not Yet Celebration
Price transparency has long eluded the health care industry, but change — fueled by rare bipartisan support — is afoot.

Price transparency has long eluded the health care industry, but change — fueled by rare bipartisan support — is afoot.

This digital symposium explores recommendations for the Biden/Harris administration’s health policy agenda.

Psychedelic drug reform is not occurring at the expense of other drug reforms. Instead, it paves the way for larger reforms.

The Biden administration should work with Congress to add clearer nondiscrimination protections to the ACA.

Revocations through the administrative process could undermine the stability of all waivers, but revocations through the CRA would not.
